ArticleOncotarget2018

Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases.

Leticia De Mattos-Arruda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.